Contact details

Dan Holland

T: +44 20 7809 2108 M: +44 7841 923 656 Email Dan | vCard Office: London

Awards

Commercial contracts

Commercial contracts

Life sciences and healthcare

Life sciences and healthcare

Commercial contracts, IP - Patents (Contentious and non contentious), IT and Telecoms and Life sciences

Commercial contracts, IP - Patents (Contentious and non contentious), IT and Telecoms and Life sciences

Dan Holland Partner

Contact details

Dan Holland

Dan Holland
Partner

T: +44 20 7809 2108 M: +44 7841 923 656 Email Dan | vCard Office: London

A commercial lawyer with a focus on outsourcing, manufacturing and supply chain issues. Dan has 20 years' experience in advising on a wide variety of commercial relationships, from day-to-day trading activities to one-off projects and strategic alliances.
  • Profile
  • Services
  • Sectors

Dan's practice is broadly split between services and supply chain issues, including procurement and supply at all stages of production, and outsourcing of both IT and BPO services. His practice is particularly focussed on the life sciences, manufacturing, transport and financial services sectors.

His recent outsourcing experience includes the provision of hosted software and managed services to provide core banking function in a regulated environment to banks in the UK, as well as provision of other payment technology. On the BPO side, he has advised on the provision of crew, catering and lounge services on Eurostar trains.

In life sciences, Dan regularly advises on the manufacturing and distribution of both API and finished products in the UK and Europe. He has particular knowledge of centralised procurement structures, consignment manufacturing arrangements and all routes to market for goods.

Dan’s practice covers clients in the UK as well as those based throughout Europe, the Middle East and the US. He worked in Paris for a number of years and speaks fluent French.

"He is very approachable and a good, collaborative lawyer."
Chambers UK 2019

  • Commercial, outsourcing and technology

FIS

Advising in relation to a number of agreements for the provision of IT platforms for the hosting of customer accounts, call centres and a range of ancillary services

Chef Express

Advising on the provision of crew, catering and lounge services to Eurostar.

Post Office

Advising on issues relating to the separation of the business of the Post Office from Royal Mail

Life Sciences Company

Advising on the arrangements for the manufacture and distribution of a PET tracer for the detection of Alzheimer's disease

O-I Europe

Advising on a range of consignment manufacturing arrangements and sales agreements across Europe

More: Commercial, outsourcing and technology

  • Life sciences
  • Technology
  • Food and drink

Oxford Biomedica

Advising in relation to a number of agreements relating to the manufacture of AZD1222, the Covid-19 vaccine candidate developed by the University of Oxford and commercialised and distributed by AstraZeneca.

Oxford Biomedica

Advising in relation to its Licence and Clinical Supply Agreement with Juno Therapeutics, part of Bristol Myers Squibb.

A biochemistry laboratory

Advising in relation to a number of outsourcing agreements for core business services outside the US.

Incyte Corporation

Advising in relation to a number of clinical and commercial supply arrangements with partners in Europe and China.

UCB 

Advising in relation to manufacturing, services agreements, research collaboration agreements, material transfer agreements, CRO agreements and facilitated management arrangements.

A viral vector contract development and manufacturing company

Advising in relation to a number of clinical and commercial supply agreements for the manufacture and supply of viral vectors.

BTG Plc

Drafting of a template distribution agreement.

Life sciences company

Advising on the arrangements for the manufacture and distribution of a PET tracer for the detection of Alzheimer's disease.

Life sciences company

Advising on the supply arrangements following the insolvency of a sole supplier.

Life sciences company

Advising on the European distribution agreements for a cancer treatment.

More: Life sciences

FIS

Advising in relation to a number of agreements for the provision of IT platforms for the hosting of customer accounts, call centres and a range of ancillary services.

Post Office

Advising on issues relating to the separation of IT systems from Royal Mail.

Stolt

Advising on the establishment of a platform for online booking of freight by land and sea.

More: Technology

Aviagen

Advising on agreements for the distribution of poultry throughout Europe, the Middle East and Africa.

Senoble UK

Advising on agreements for the procurement of raw materials and issues relating to the supply to supermarkets.

O-I Europe

Advising on agreements for the supply of glass packaging to multi-national drinks companies for over 10 years.

More: Food and drink

Awards

Commercial contracts

Commercial contracts

Life sciences and healthcare

Life sciences and healthcare

Commercial contracts, IP - Patents (Contentious and non contentious), IT and Telecoms and Life sciences

Commercial contracts, IP - Patents (Contentious and non contentious), IT and Telecoms and Life sciences

Latest news & insights

13 Apr 2023

From Insights

Commercial and tech update - April 2023

Welcome to our latest commercial and tech update.

More

25 Aug 2022

From Insights

Commercial and tech update - August 2022

Welcome to this month’s edition of our commercial and tech update, which looks at when a liquidated damages clause could act as a general liability cap, the pitfalls o..

More

13 Jul 2022

From News

Stephenson Harwood advises Oxford Biomedica on new AstraZeneca agreement

Law firm Stephenson Harwood LLP has advised Oxford Biomedica, the gene and cell therapy company, on its new three year Master Services & Development Agreement with Ast..

More

13 Jul 2022

From Insights

Commercial and tech update - July 2022

Welcome to our latest commercial and tech update. In this edition we look at the recent High Court judgment in Force India Formula One Team Ltd, Re [2022] which provid..

More

20 Apr 2022

From Insights

Commercial and tech update - April 2022

Welcome to this month’s edition of our commercial and tech update, which looks at exclusion of liability for loss of profit clauses, the importance of clear drafting o..

More

28 Feb 2022

From Insights

Commercial and tech update - February 2022

This month’s edition looks at when incorporating terms by reference may not be sufficient, the importance of dealing with timing, how the courts might measure "reasona..

More

30 Sep 2021

From News

Stephenson Harwood advises AM-Pharma on €245 million deal

Law firm Stephenson Harwood LLP has advised AM-Pharma on its €245 million exclusive license agreement deal with Kyowa Kirin, for the development and commercialisation ..

More

29 Jun 2021

From Insights

Commercial and tech update - June 2021

This month’s update looks at two recent High Court decisions which will be useful for those drafting or interpreting contracts, as well as the decision of the CMA to i..

More

20 Jan 2021

From Insights

A tale of winners and losers: an overview of the UK/EU free trade agreement

On Christmas Eve, Boris Johnson and Ursula von der Leyen announced that they had – finally – agreed terms for a free trade agreement to apply on a provisional basis (p..

More

19 Jan 2021

From Insights

Brexit is here: What does it mean for the rail industry?

After almost three and a half years of negotiation and renegotiation, the United Kingdom, the European Atomic Energy Community, and the European Union finally agreed o..

More

21 Dec 2020

From Insights

Commercial and tech update - December 2020

Welcome to this month’s edition of our commercial and tech update, which covers the interpretation of “goodwill”, guidance for the gaming industry and the need for fai..

More

15 Oct 2020

From Insights

Commercial and tech update - October 2020

This month’s edition includes guidance for businesses post-Brexit and further clarification on the court’s approach to dealing with fraudulent payments.

More

04 Sep 2020

From News

Stephenson Harwood advises Oxford Biomedica on further Covid-19 vaccine deal

Law firm Stephenson Harwood LLP has advised gene and cell therapy company Oxford Biomedica on a second supply agreement with AstraZeneca, to expand the manufacturing s..

More

19 Jun 2020

From Insights

Commercial and tech update - June 2020

This month’s edition includes significant changes to a supplier’s right to terminate for a customer’s insolvency, as well as a cautionary tale on rectification.

More

01 Jun 2020

From News

Stephenson Harwood advises Oxford Biomedica on COVID-19 vaccine with AstraZeneca

Law firm Stephenson Harwood LLP has advised Oxford Biomedica plc (Oxford Biomedica), a gene and cell therapy company, on a Clinical and Commercial Supply Agreement wit..

More

12 May 2020

From Insights

Commercial and tech update - May 2020

This edition features a lot of information and guidance on COVID-19 developments, as well as an interesting find on a force majeure event.

More

print-footer
logo
© Stephenson Harwood LLP 2016. Any reference to Stephenson Harwood in this document means Stephenson Harwood LLP and/or its affiliated undertakings. Any reference to a partner is used to refer to a member of Stephenson Harwood LLP.